151 related articles for article (PubMed ID: 11032056)
21. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
[TBL] [Abstract][Full Text] [Related]
22. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures.
Osborne JE; Hutchinson PE
J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):367-73. PubMed ID: 12224694
[TBL] [Abstract][Full Text] [Related]
23. Management of psoriasis with calcipotriol used as monotherapy.
Ramsay CA
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
[TBL] [Abstract][Full Text] [Related]
24. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
[TBL] [Abstract][Full Text] [Related]
25. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
Hofmann UB; Eggert AA; Bröcker EB; Goebeler M
Br J Dermatol; 2003 Apr; 148(4):779-83. PubMed ID: 12752138
[TBL] [Abstract][Full Text] [Related]
26. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
27. Dithranol in a cream preparation: disperse or dissolve?
Prins M; Swinkels OQ; Bouwhuis S; de Gast MJ; Bouwman-Boer Y; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2000; 13(5):273-9. PubMed ID: 10940817
[TBL] [Abstract][Full Text] [Related]
28. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis.
Fredriksson T
Pharmatherapeutica; 1983; 3(7):496-8. PubMed ID: 6366807
[TBL] [Abstract][Full Text] [Related]
30. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
[TBL] [Abstract][Full Text] [Related]
31. Calcipotriol. A new topical antipsoriatic.
Kragballe K; Iversen L
Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
[TBL] [Abstract][Full Text] [Related]
32. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
33. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014
[TBL] [Abstract][Full Text] [Related]
34. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh P; Gupta S; Abidi A; Krishna A
J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
[TBL] [Abstract][Full Text] [Related]
37. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis.
Duweb GA; Abuzariba O; Rahim M; al-Taweel M; al-Alem S; Abdulla SA
Int J Tissue React; 2001; 23(2):59-62. PubMed ID: 11447774
[TBL] [Abstract][Full Text] [Related]
38. Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis.
Sharma V; Kaur I; Kumar B
Int J Dermatol; 2003 Oct; 42(10):834-8. PubMed ID: 14521705
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis.
Tham SN; Lun KC; Cheong WK
Br J Dermatol; 1994 Nov; 131(5):673-7. PubMed ID: 7999599
[TBL] [Abstract][Full Text] [Related]
40. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
